alluvi-peptides579282 - Profile

About me

Profile

Alluvi, known as BI 4744, offers a significant development in obesity treatment. This dual agonist targeting both GLP-1 and glucose-dependent insulinotropic polypeptide receptors demonstrates

https://alluvi-research.co.uk/